INSIGHTS ON DRUG DEVELOPMENT

• Beyond SOPs: Assessing Quality Of CDMOs

  When choosing a CDMO partner, it is essential to prioritize quality. Discover how the right partner can instill confidence in the safety and effectiveness of your pharmaceutical products.

• Mitigating Early Development Risks

  Discover how the efficient screening of biologic candidates accelerates the discovery process, reduces costs, and improves the likelihood of commercializing safe and effective drugs.

• Futurizing Healthcare By Localizing The Life Sciences

  Mustapha Bittaye's journey highlights the importance of international funding in fostering local scientific talent and biopharma resilience, empowering research and manufacturing in developing countries.

• Characterizing Binding Interactions By ITC

  Isothermal Titration Calorimetry is a powerful technique for analyzing biochemical binding events, which is crucial for understanding molecular interactions and enzyme kinetics in biomedical research.

• Matrix Approach Enhances Potency Assay Development For ATMPs

  12/22/2025

  Potency assays for ATMPs demand precision. Learn how a matrix approach, regulatory alignment, and advanced technologies can overcome variability and ensure safety throughout the product lifecycle.

• Accelerating Development With Rapid Delivery Of Toxicological Study Material

  3/19/2025

  Explore key strategies and technologies designed to address the analytical considerations and material flows to facilitate the rapid delivery of toxicological material.

• Highly Sensitive ELISAs In 90 Minutes

  9/11/2024

  Traditional ELISA methods are often limited by their relatively low throughput and need for multiple wash steps. Learn about a solution that overcomes these challenges and provides rapid results.

• Quantification Of Exenatide Using Xevo TQD

  7/29/2025

  Discover a highly sensitive and reliable LC-MS/MS method for quantifying exenatide in plasma that is powered by advanced sample prep and optimized column chemistries.

• Understanding Adeno-Associated Virus Vector Impurities

  11/13/2025

  AAV vectors hold promise for gene therapy, but removing product-related impurities remains a challenge. Learn how cell line development and process optimization are advancing rAAV production.